Allermi: Funding, Investors & Team (Aug 2026)
Allermi is the initial company to provide personalized prescription allergy medications directly to consumers. These medications are developed by top allergists, and we aim to provide relief by giving patients access to certified allergists, evidence-based medicine, and personalized treatments.
Allermi has raised $4.8M across 3 funding rounds on record, the most recent a Series A announced in Apr 2024.
Allermi Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Allermi Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Allermi raised $1.3M in a Pre-Seed announced in Sep 2022.
6 months later, a Seed of $3.5M was announced in Mar 2023.
1.1 years later, a Series A was announced in Apr 2024 with no disclosed amount.
Allermi Founders and Leadership Team
Contact details for the Allermi team: 1 of 1 has an email address on file.
Start 14-day free trial →Allermi Funding Compared to Other Health Care Startups
Funded Startups Like Allermi in Health Care and San Francisco
Companies Similar to Allermi
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Allermi Funding FAQs
What does Allermi do?
Allermi is the initial company to provide personalized prescription allergy medications directly to consumers. These medications are developed by top allergists, and we aim to provide relief by giving patients access to certified allergists, evidence-based medicine, and personalized treatments.
How much funding has Allermi raised?
Allermi has raised $4.8M across 3 rounds on record.
When did Allermi last raise funding?
Allermi's most recent funding round on record was announced in Apr 2024. The amount was not disclosed.
Who is the CEO of Allermi?
Shani Bocian Steinberg is listed as CEO at Allermi.
Where is Allermi headquartered?
Allermi is based in San Francisco, California, United States.
How many employees does Allermi have?
Allermi is in the 1-10 employee band.
About FundedIQ's Allermi Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Allermi is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.